{"id":26759,"date":"2024-07-04T13:15:00","date_gmt":"2024-07-04T11:15:00","guid":{"rendered":"https:\/\/qlinea.com\/mfn_news\/inbjudan-till-presentation-av-q-lineas-delarsrapport-for-kvartal-2-2024-den-11-juli-2024\/"},"modified":"2024-07-04T14:36:50","modified_gmt":"2024-07-04T12:36:50","slug":"inbjudan-till-presentation-av-q-lineas-delarsrapport-for-kvartal-2-2024-den-11-juli-2024","status":"publish","type":"mfn_news","link":"https:\/\/qlinea.com\/sv\/mfn_news\/inbjudan-till-presentation-av-q-lineas-delarsrapport-for-kvartal-2-2024-den-11-juli-2024\/","title":{"rendered":"Inbjudan till presentation av Q-lineas del\u00e5rsrapport f\u00f6r kvartal 2, 2024 den 11 juli, 2024"},"content":{"rendered":"<div class=\"mfn-preamble\">\n<p class=\"mfn-wp-retain\"><strong>Q-linea AB (publ) (Nasdaq Stockholm: QLINEA), publicerar bolagets del&aring;rsrapport f&ouml;r perioden januari &ndash; juni 2024, torsdagen den 11 juli 2024, klockan 07:30 (CEST).<\/strong><\/p>\n<\/div>\n<div class=\"mfn-body\">\n<p class=\"mfn-wp-retain\">Q-linea bjuder in till en audiocast med telefonkonferens (p&aring; engelska) eller webcast f&ouml;r investerare, analytiker och media den 11 juli, 2024, klockan 13:00 &ndash; 14:00 (CEST).<\/p>\n<p class=\"mfn-wp-retain\">Stuart Gander, Koncernchef och Christer Samuelsson, CFO\/IR kommer att presentera Q-linea och kommentera del&aring;rsrapporten f&ouml;ljt av en fr&aring;gestund.<\/p>\n<p class=\"mfn-wp-retain\">Om du &ouml;nskar delta via webcast g&aring; in p&aring; l&auml;nk:<br \/><a href=\"https:\/\/ir.financialhearings.com\/q-linea-q2-report-2024\" rel=\"noopener\" target=\"_blank\">https:\/\/ir.financialhearings.com\/q-linea-q2-report-2024<\/a>&nbsp;<br \/>Via webcast finns m&ouml;jlighet att st&auml;lla skriftliga fr&aring;gor.<\/p>\n<p class=\"mfn-wp-retain\">Om du &ouml;nskar st&auml;lla muntliga fr&aring;gor via telefonkonferens registrerar du dig via l&auml;nken:<br \/><a href=\"https:\/\/conference.financialhearings.com\/teleconference\/?id=50048292\" rel=\"noopener\" target=\"_blank\">https:\/\/conference.financialhearings.com\/teleconference\/?id=50048292<\/a><br \/>Efter registreringen f&aring;r du telefonnummer och ett konferens-ID f&ouml;r att logga in till konferensen. Via telefonkonferensen finns m&ouml;jlighet att st&auml;lla muntliga fr&aring;gor.<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-contacts mfn-828219978778\">\n<p class=\"mfn-wp-retain\"><strong class=\"mfn-heading-1\">F&ouml;r mer information, v&auml;nligen kontakta:<\/strong><\/p>\n<hr>\n<p class=\"mfn-wp-retain\">Stuart Gander, President &amp; CEO, Q-linea <br \/><a href=\"m&#97;&#105;&#x6c;&#x74;&#x6f;:s&#116;&#117;&#x61;&#x72;&#x74;&#46;&#103;&#97;&#110;&#x64;&#x65;&#x72;&#64;&#113;&#108;&#x69;&#x6e;&#x65;a&#46;&#99;&#111;&#x6d;\" rel=\"noopener\" target=\"_blank\">&#83;&#x74;&#117;&#x61;&#114;&#x74;&#46;&#x47;a&#x6e;d&#101;&#x72;&#64;&#x71;&#108;&#x69;&#110;&#x65;a&#x2e;c&#x6f;m<\/a><br \/>+1 857 409 7463<\/p>\n<p class=\"mfn-wp-retain\">Christer Samuelsson, CFO \/ IR, Q-linea AB<br \/><a href=\"m&#97;&#x69;&#x6c;&#x74;o&#58;&#67;&#x68;&#x72;i&#115;&#116;&#x65;&#x72;&#46;S&#97;&#x6d;&#x75;&#x65;l&#115;&#x73;&#x6f;&#x6e;&#64;&#113;&#108;&#x69;&#x6e;e&#97;&#46;&#x63;&#x6f;m\" rel=\"noopener\" target=\"_blank\">&#67;&#x68;&#114;&#x69;&#115;&#x74;&#101;&#x72;&#46;&#x53;a&#x6d;u&#x65;l&#115;&#x73;&#111;&#x6e;&#64;&#x71;&#108;&#x69;&#110;&#x65;a&#x2e;c&#x6f;m<\/a><br \/>+ 46 (0) 70-600 15 20<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about mfn-2048cb62925b\">\n<p class=\"mfn-wp-retain\"><strong class=\"mfn-heading-1\">Om Q-linea<\/strong><\/p>\n<hr>\n<p class=\"mfn-wp-retain\">Q-lineas ASTar&reg; f&ouml;r snabb resistensbest&auml;mning kortar svarstiderna vid diagnostik av tidskritiska sjukdomstillst&aring;nd som blodomloppsinfektioner och sepsis. Sjukhus anv&auml;nder ASTar f&ouml;r att avsev&auml;rt minska tiden till optimal antibiotikabehandling och se till att patienter f&aring;r r&auml;tt behandling, med r&auml;tt dos, i r&auml;tt tid. Vi bidrar till en h&aring;llbar sjukv&aring;rd, nu och i framtiden, och v&auml;rnar om att antibiotika &auml;r effektivt &auml;ven f&ouml;r kommande generationer.<br \/>Q-linea har sitt huvudkontor i Uppsala, Sverige, regionala kontor i Italien och USA, samt partnerskap &ouml;ver hela v&auml;rlden. <br \/>ASTar Instrument och ASTar BC G- Consumables kit &auml;r CE-IVD-m&auml;rkta och FDA 510(k)-godk&auml;nda. F&ouml;r mer information, bes&ouml;k <a href=\"http:\/\/www.qlinea.com\" rel=\"noopener\" target=\"_blank\">www.qlinea.com<\/a>.<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-attachment mfn-attachment-general\">\n<p class=\"mfn-wp-retain\"><strong class=\"mfn-heading-1\">Bifogade filer<\/strong><\/p>\n<hr>\n<p class=\"mfn-wp-retain\"><a class=\"mfn-generated mfn-primary\" href=\"https:\/\/storage.mfn.se\/b185c0fb-5c72-4288-bc5e-7b865a89a0ef\/inbjudan-till-presentation-av-q-lineas-delarsrapport-for-kvartal-2-2024-den-11-juli-2024.pdf\" rel=\"noopener\" target=\"_blank\">Inbjudan till presentation av Q-lineas del&aring;rsrapport f&ouml;r kvartal 2, 2024 den 11 juli, 2024<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Q-linea AB (publ) (Nasdaq Stockholm: QLINEA), publicerar bolagets del&aring;rsrapport f&ouml;r perioden januari &ndash; juni 2024, torsdagen den 11 juli 2024, klockan 07:30 (CEST). Q-linea bjuder&#8230;<\/p>\n","protected":false},"template":"","class_list":["post-26759","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-ci-sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"_links":{"self":[{"href":"https:\/\/qlinea.com\/sv\/wp-json\/wp\/v2\/mfn_news\/26759","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/qlinea.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/qlinea.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/qlinea.com\/sv\/wp-json\/wp\/v2\/media?parent=26759"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}